Cost-benefit analysis of arpraziquantel compared to standard of care for schistosomiasis among pre-school age children in Tanzania: an early health economic evaluation

The Lancet Regional Health - Africa · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles